Skip to Content
Merck
CN
All Photos(1)

Documents

16374

Sigma-Aldrich

4-Bromobenzenesulfonamide

≥99.0% (T)

Sign Into View Organizational & Contract Pricing

Empirical Formula (Hill Notation):
C6H6BrNO2S
CAS Number:
Molecular Weight:
236.09
Beilstein:
2691657
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Quality Level

Assay

≥99.0% (T)

form

solid

SMILES string

NS(=O)(=O)c1ccc(Br)cc1

InChI

1S/C6H6BrNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10)

InChI key

STYQHICBPYRHQK-UHFFFAOYSA-N

Related Categories

General description

4-Bromobenzenesulfonamide is a metabolite of ebrotidine, a new H2-receptor antagonist.

Application

4-Bromobenzenesulfonamide was used as reagent in preparation of cobalt(III) complexes of N,R-sulfonyldithiocarbimate anion. It was also used in the synthesis of 2-, 3- and 4-(substituted-phenylethynyl)benzenesulfonamides.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Preparation of novel cobalt (III) complexes with dithiocarbimates derived from sulfonamides.
Oliveira MRL and Bellis VMD.
Transition Metal Chemistry, 24(2), 127-130 (1999)
E Rozman et al.
Journal of pharmaceutical sciences, 83(2), 252-254 (1994-02-01)
Ebrotidine is a new H2-receptor antagonist which exhibits a remarkable ability for gastric mucosal protection. A preliminary metabolic pathway for this compound was proposed and the hypothetic metabolites were synthesized. The presence of ebrotidine and its metabolites ebrotidine S-oxide and
Raymond Anana et al.
Bioorganic & medicinal chemistry, 14(15), 5259-5265 (2006-04-26)
A group of regioisomeric phenylethynylbenzenesulfonamides possessing a COX-2 SO2NH2 pharmacophore at the para-, meta- or ortho-position of the C-1 phenyl ring, in conjunction with a C-2 substituted-phenyl (H, OMe, OH, Me, F) group, were synthesized and evaluated as inhibitors of
S Sentellas et al.
Electrophoresis, 22(1), 71-76 (2001-02-24)
This paper illustrates the possibilities of chemometric methods in the resolution and quantification of various compounds in overlapping peaks from capillary electrophoresis. Ebrotidine and most of its metabolites were efficiently separated by capillary zone electrophoresis (CZE) in a fused-silica capillary.
Gloria Uccello-Barretta et al.
Bioorganic & medicinal chemistry, 12(2), 447-458 (2004-01-16)
NMR spectroscopic and molecular modelling methods have been employed to describe the complexation of trans-N-4-[N'-(4-chlorobenzoyl)hydrazinocarbonyl]cyclohexylmethyl-4-bromobenzenesulfonamide, a new chemotype of NPY-5 antagonist, and beta-cyclodextrin, revealing the coexistence of two different kinds of 1:1 complexes where conformational changes of the guest compound

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service